{"doc_id": "si-2021-0558-reg-1", "parent_doc_id": "si-2021-0558", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 558 of 2021", "title": "Products (Prescription and Control of Supply) Regulations 2003 (S.I. No. 540", "year": 2021, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n(Prescription and Control of Supply) (Amendment) (No. 11) Regulations 2021. \n\n(2) The collective citation “the Medicinal Products (Prescription and \n\nControl of Supply) Regulations 2003 to 2021” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 11) regulation 2021 (2) collective citation medicinal product (prescription control supply) regulation 2003 2021 includes regulation", "start_char": 642, "end_char": 932, "source_path": "downloads\\2021\\2021_0558.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a3036285835a86888fbbc038710dbd96f6abbcff87017905a7b5d7a180b7d729", "cross_refs": []}
{"doc_id": "si-2021-0558-reg-2", "parent_doc_id": "si-2021-0558", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 558 of 2021", "title": "Products (Prescription and Control of Supply) Regulations 2003 (S.I. No. 540", "year": 2021, "heading": "In these Regulations “Principal Regulations” means the Medicinal", "text_raw": "2. \n\nIn these Regulations “Principal Regulations” means the Medicinal \nProducts (Prescription and Control of Supply) Regulations 2003 (S.I. No. 540 \nof 2003).", "text_norm": "2 regulation principal regulation mean medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003)", "start_char": 932, "end_char": 1093, "source_path": "downloads\\2021\\2021_0558.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a3036285835a86888fbbc038710dbd96f6abbcff87017905a7b5d7a180b7d729", "cross_refs": []}
{"doc_id": "si-2021-0558-reg-3", "parent_doc_id": "si-2021-0558", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 558 of 2021", "title": "Products (Prescription and Control of Supply) Regulations 2003 (S.I. No. 540", "year": 2021, "heading": "3. The Eighth Schedule (as amended by Regulation 3 of the Medicinal", "text_raw": "3. The Eighth Schedule (as amended by Regulation 3 of the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 9) \nRegulations 2021 (S.I. No. 492 of 2021)) to the Principal Regulations is \namended, in column 5 of the entry for the medicinal product “Comirnaty \nconcentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside \nmodified)”— \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\nin subparagraph (a), by inserting “against Covid-19” after \n“already received a primary vaccine course”, \n\nin subparagraph (a)(iv), by substituting “legal guardian),” for \n“legal guardian), and”, \n\nin subparagraph (b), by inserting “against Covid-19” after \n“already received a primary vaccine course”, \n\nin subparagraph (b)(iii), by substituting “is obtained, and” for “is \nobtained.”, and \n\n(e) \n\nby inserting after subparagraph (b) the following subparagraph: \n\n“(c) a booster or subsequent dose may be administered to a \nperson who has already received a primary vaccine course \nagainst Covid-19 listed in this Schedule where— \n\n(i) \n\nthe person is between 60 and 79 years of age, \n\n(ii) 5 months or more have passed since \n\nthe \nadministration of the said primary vaccine course, \nand \n\n(iii) \n\ninformed consent is obtained.”. \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 29th October, 2021. \n\n \n \n \n \n \n \n \n\f[558] 3", "text_norm": "3 eighth schedule (as amended regulation 3 medicinal product (prescription control supply) (amendment) (no 9) regulation 2021 (s.i no 492 2021)) principal regulation amended column 5 entry medicinal product comirnaty concentrate dispersion injection covid-19 mrna vaccine (nucleoside modified) -- (a) (b) (c) (d) subparagraph (a) inserting covid-19 already received primary vaccine course subparagraph (a)(iv) substituting legal guardian) legal guardian) subparagraph (b) inserting covid-19 already received primary vaccine course subparagraph (b)(iii) substituting obtained obtained (e) inserting subparagraph (b) following subparagraph (c) booster subsequent dose may administered person already received primary vaccine course covid-19 listed schedule where-- (i) person 60 79 year age (ii) 5 month passed since administration said primary vaccine course (iii) informed consent obtained  notice making statutory instrument published iris oifigiuil 29th october 2021 558 3", "start_char": 1093, "end_char": 2458, "source_path": "downloads\\2021\\2021_0558.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a3036285835a86888fbbc038710dbd96f6abbcff87017905a7b5d7a180b7d729", "cross_refs": []}
{"doc_id": "si-2021-0558-reg-4", "parent_doc_id": "si-2021-0558", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 558 of 2021", "title": "Products (Prescription and Control of Supply) Regulations 2003 (S.I. No. 540", "year": 2021, "heading": "4. The Twelfth Schedule (as amended by Regulation 5 of the Medicinal", "text_raw": "4. The Twelfth Schedule (as amended by Regulation 5 of the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 10) \nRegulations 2021 (S.I. No. 511 of 2021)) to the Principal Regulations is \namended, in column 5 of the entry for the medicinal product “Comirnaty \nconcentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside \nmodified)”— \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\nin subparagraph (a), by inserting “against Covid-19” after \n“already received a primary vaccine course”, \n\nin subparagraph (a)(iv), by substituting “legal guardian),” for \n“legal guardian), and”, \n\nin subparagraph (b), by inserting “against Covid-19” after \n“already received a primary vaccine course”, \n\nin subparagraph (b)(iii), by substituting “is obtained, and” for “is \nobtained.”, and \n\n(e) \n\nby inserting after subparagraph (b) the following subparagraph: \n\n“(c) a booster or subsequent dose may be administered to a \nperson who has already received a primary vaccine course \nagainst Covid-19 listed in this Schedule where— \n\n(i) \n\nthe person is between 60 and 79 years of age, \n\n(ii) 5 months or more have passed since \n\nthe \nadministration of the said primary vaccine course, \nand \n\n(iii) \n\ninformed consent is obtained.”. \n\nGIVEN under my Official Seal, \n\n27 October, 2021. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n\f4 [558]", "text_norm": "4 twelfth schedule (as amended regulation 5 medicinal product (prescription control supply) (amendment) (no 10) regulation 2021 (s.i no 511 2021)) principal regulation amended column 5 entry medicinal product comirnaty concentrate dispersion injection covid-19 mrna vaccine (nucleoside modified) -- (a) (b) (c) (d) subparagraph (a) inserting covid-19 already received primary vaccine course subparagraph (a)(iv) substituting legal guardian) legal guardian) subparagraph (b) inserting covid-19 already received primary vaccine course subparagraph (b)(iii) substituting obtained obtained (e) inserting subparagraph (b) following subparagraph (c) booster subsequent dose may administered person already received primary vaccine course covid-19 listed schedule where-- (i) person 60 79 year age (ii) 5 month passed since administration said primary vaccine course (iii) informed consent obtained  given official seal 27 october 2021 stephen donnelly minister health 4 558", "start_char": 2458, "end_char": 3811, "source_path": "downloads\\2021\\2021_0558.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a3036285835a86888fbbc038710dbd96f6abbcff87017905a7b5d7a180b7d729", "cross_refs": []}
{"doc_id": "si-2021-0558-explanatory-note", "parent_doc_id": "si-2021-0558", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 558 of 2021", "title": "Products (Prescription and Control of Supply) Regulations 2003 (S.I. No. 540", "year": 2021, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to allow booster/subsequent doses of the \nCominarty COVID-19 vaccine to be supplied and administered to certain \npersons. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 11) Regulations 2021. \n\n \n \n \n \n \n \n \n \n\f[558] 5 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€3.00 \n\n(DH-313) 75. 10/21. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation allow booster subsequent dos cominarty covid-19 vaccine supplied administered certain person regulation may cited medicinal product (prescription control supply) (amendment) (no 11) regulation 2021 558 5 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur3.00 (dh-313) 75 10 21 propylon", "start_char": 3811, "end_char": 4837, "source_path": "downloads\\2021\\2021_0558.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a3036285835a86888fbbc038710dbd96f6abbcff87017905a7b5d7a180b7d729", "cross_refs": []}
